Clinical trial

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

NCT01044576

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-01-01

PhaseN/A

Study timeline

Study start (actual)2010-01-01Date precision: month

Registry last updated2021-03-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-remitting Multiple Sclerosisverified · MONDO: relapsing-remitting multiple sclerosis

Secondary Progressive Multiple Sclerosisverified · MONDO: secondary progressive multiple sclerosis

Interventions

Sponsors & collaborators

Imperial College Londonlead sponsor

Medical Research Councilcollaborator

Imperial College Healthcare NHS Trustcollaborator

University College, Londoncollaborator

Queen Mary University of Londoncollaborator

GlaxoSmithKlinecollaborator

University of Cambridgecollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01044576 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.